Some studies have reported NGAL to be a definitive biomarker for AKI [30,31,32] while others have acknowledged the utility of NGAL but do not yet consider it to be a gold standard marker for early detection of AKI [33,34]. This evidence concerns the gene LCN2 and acute kidney injury.